Cargando…
Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer.
The prognostic role of drug-induced amenorrhea (DIA) was restrospectively evaluated in 221 out of 254 consecutive premenopausal patients treated with adjuvant CMF or a CMF-containing regimen; 33 patients were eliminated because of lack of menstrual data. All patients had metastatic axillary nodes; d...
Autores principales: | Bianco, A. R., Del Mastro, L., Gallo, C., Perrone, F., Matano, E., Pagliarulo, C., De Placido, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972375/ https://www.ncbi.nlm.nih.gov/pubmed/2039706 |
Ejemplares similares
-
Prognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients
por: Jeon, Se Jeong, et al.
Publicado: (2016) -
Prognostic impact of chemotherapy-induced amenorrhea on premenopausal breast cancer: a meta-analysis of the literature
por: Zhou, Qiong, et al.
Publicado: (2015) -
Chemotherapy-Induced Amenorrhea and Its Prognostic Significance in Premenopausal Women With Breast Cancer: An Updated Meta-Analysis
por: Wang, Yifei, et al.
Publicado: (2022) -
Chemotherapy-Related Amenorrhea and Quality of Life Among Premenopausal Women With Breast Cancer
por: Kabirian, Rayan, et al.
Publicado: (2023) -
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.
por: De Placido, S., et al.
Publicado: (1990)